For gout, xanthine oxidase (XO) inhibitors are the choice for first-line urate-lowering therapy (ULT) according to the 2020 American College of Rheumatology Guideline for the Management of Gout, which ...
A newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout medication allopurinol in U.S. patients. While the gene HLA-B*58:01 has long ...
A multi-institutional study led by a Massachusetts General Hospital (MGH) investigator finds significant racial disparities in the risk that patients being treated for gout will develop a serious, ...
A newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout medication allopurinol in U.S. patients. While the gene HLA-B*58:01 has long ...
Please provide your email address to receive an email when new articles are posted on . “Therefore, it is very important for patients and clinicians alike to be aware of the cardiovascular safety of ...
The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which as no cure to date. This disease ...
The current test uses only one of the genes, and it misses many patients at risk FRIDAY, Oct. 31, 2025 (HealthDay News) — A new gene test might be able to predict which gout patients will have a bad ...
LONDON, June 8 (Reuters) - A drug used for more than 40 years to treat gout could also offer a cheap alternative to more modern heart drugs from Roche and Servier for patients with chronic chest pain, ...
Atom Therapeutics is touting data from a phase 2b/3 study as evidence that its gout drug has the efficacy and safety profile to stand out from the competition. The Chinese biotech evaluated the oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback